Molecular epidemiology and interferon susceptibility of the natural recombinant hepatitis C virus strain RF1_2k/1b

Journal of Infectious Diseases

Volumn 198, Issue 10, 2008, Pages 1448-1456

  Kurbanov, Fuat ^a   Tanaka, Yasuhito ^a   Chub, Elena ^a,e   Maruyama, Isao ^c   Azlarova, Aziza ^a,f   Kamitsukasa, Hiroshi ^d   Ohno, Tomoyoshi ^b   Bonetto, Stefania ^g   Moreau, Isabelle ^h   Fanning, Liam J ^h   Legrand Abravane, Florence ⁱ   Izopet, Jaques ⁱ   Naoumov, Nikolai ^g   Shimada, Takashi ^c   Netesov, Sergei ^e   Mizokami, Masashi ^a  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^b CHUKYO HOSPITAL   (Japan)

^c PhoenixBio USA Corporation   (Japan)

^d TOKYO NATIONAL HOSPITAL   (Japan)

^e STATE RESEARCH CENTER OF VIROLOGY AND BIOTECHNOLOGY VECTOR   (Russian Federation)

^f Ministry of Health Uzbekistan   (Uzbekistan)

^g UNIVERSITY COLLEGE LONDON   (United Kingdom)

^h University College Cork and INFANT Centre   (Ireland)

ⁱ INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PEGINTERFERON ALPHA2A; RIBAVIRIN; VIRUS RNA;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHIMERA; CONTROLLED STUDY; DRUG SENSITIVITY; FEMALE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LIVER CELL; MAJOR CLINICAL STUDY; MALE; MOLECULAR EPIDEMIOLOGY; MOLECULAR EVOLUTION; MONOTHERAPY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RUSSIAN FEDERATION; STRAIN DIFFERENCE; UZBEKISTAN; VIRUS LOAD; VIRUS RECOMBINATION; VIRUS STRAIN;

ADULT; ANIMALS; ANTIVIRAL AGENTS; EPIDEMIOLOGY, MOLECULAR; EVOLUTION, MOLECULAR; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HUMANS; INTERFERON ALFA-2A; MALE; MICE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; POLYETHYLENE GLYCOLS; RECOMBINATION, GENETIC; RIBAVIRIN; YOUNG ADULT;

EID: 54949116213     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/592757     Document Type: Article

References (38)

1. Simmonds P, Bukh J, Combet C, et al. Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology 2005; 42:962-73.
2. Zein NN. Clinical significance of hepatitis C virus genotypes. Clin Microbiol Rev 2000; 13:223-35.
3. Scott JD, Gretch DR. Molecular diagnostics of hepatitis C virus infection: a systematic review. JAMA 2007; 297:724-32.
4. Kalinina O, Norder H, Mukomolov S, Magnius LO. A natural intergenotypic recombinant of hepatitis C virus identified in St. Petersburg. J Virol 2002; 76:4034-43.
5. Kageyama S, Agdamag DM, Alesna ET, et al. A natural inter-genotypic (2b/1b) recombinant of hepatitis C virus in the Philippines. J Med Virol 2006; 78:1423-8.
6. Moreau I, Hegarty S, Levis J, et al. Serendipitous identification of natural intergenotypic recombinants of hepatitis C in Ireland. Virol J 2006; 3:95.
7. Legrand-Abravanel F, Claudinon J, Nicot F, et al. New natural intergenotypic (2/5) recombinant of hepatitis C virus. J Virol 2007; 81:4357-62.
8. Noppornpanth S, Lien TX, Poovorawan Y, Smits SL, Osterhaus AD, Haagmans BL. Identification of a naturally occurring recombinant genotype 2/6 hepatitis C virus. J Virol 2006; 80:7569-77.
9. Tallo T, Norder H, Tefanova V, et al. Genetic characterization of hepatitis C virus strains in Estonia: fluctuations in the predominating subtype with time. J Med Virol 2007; 79:374-82.
10. Kurbanov F, Tanaka Y, Avazova D, et al. Detection of hepatitis C virus natural recombinant RF1_2k/1b strain among intravenous drug users in Uzbekistan. Hepatol Res 2007; 38:457-64.
11. Tateno C, Yoshizane Y, Saito N, et al. Near completely humanized liver in mice shows human-type metabolic responses to drugs. Am J Pathol 2004; 165:901-12.
12. Meuleman P, Libbrecht L, De Vos R, et al. Morphological and biochemical characterization of a human liver in a uPA-SCID mouse chimera. Hepatology 2005; 41:847-56.
13. Nakagawa S, Umehara T, Matsuda C, Kuge S, Sudoh M, Kohara M. Hsp90 inhibitors suppress HCV replication in replicon cells and humanized liver mice. Biochem Biophys Res Commun 2007; 353:882-8.
14. Takeuchi T, Katsume A, Tanaka T, et al. Real-time detection system for quantification of hepatitis C virus genome. Gastroenterology 1999; 116:636-42.
15. Ohno O, Mizokami M, Wu RR, et al. New hepatitis C virus (HCV) genotyping system that allows for identification of HCV genotypes 1a, 1b, 2a, 2b, 3a, 3b, 4, 5a, and 6a. J Clin Microbiol 1997; 35:201-7.
16. Hashimoto M, Chayama K, Tubota A, et al. Typing six major hepatitis C virus genotypes by polymerase chain reaction using primers derived from nucleotide sequences of the NS5 region. Int Hepatol Commun 1996; 4:263-7.
17. Tanaka Y, Hanada K, Mizokami M, et al. A comparison of the molecular clock of hepatitis C virus in the United States and Japan predicts that hepatocellular carcinoma incidence in the United States will increase over the next two decades. Proc Natl Acad Sci U S A 2002; 99:15584-9.
18. Shin IT, Tanaka Y, Tateno Y, Mizokami M. Development and public release of a comprehensive hepatitis virus database. Hepatol Res 2008; 38:234-43.
19. Kuiken C, Mizokami M, Deleage G, et al. Hepatitis C databases, principles and utility to researchers. Hepatology 2006; 43:1157-65.
20. Thomas F, Nicot F, Sandres-Saune K, et al. Genetic diversity of HCV genotype 2 strains in south western France. J Med Virol 2007; 79:26-34.
21. Samokhvalov EI, Hijikata M, Gylka RI, Lvov DK, Mishiro S. Fullgenome nucleotide sequence of a hepatitis C virus variant (isolate name VAT96) representing a new subtype within the genotype 2 (arbitrarily 2k). Virus Genes 2000; 20:183-7.
22. Kalinina O, Norder H, Magnius LO. Full-length open reading frame of a recombinant hepatitis C virus strain from St Petersburg: proposed mechanism for its formation. J Gen Virol 2004; 85:1853-7.
23. Enomoto N, Sakuma I, Asahina Y, et al. Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection. N Engl J Med 1996; 334:77-81.
24. Colina R, Casane D, Vasquez S, et al. Evidence of intratypic recombination in natural populations of hepatitis C virus. J Gen Virol 2004; 85:31-7.
25. Moreno MP, Casane D, Lopez L, Cristina J. Evidence of recombination in quasispecies populations of a hepatitis C virus patient undergoing anti-viral therapy. Virol J 2006; 3:87.
26. Akuta N, Suzuki F, Sezaki H, et al. Association of amino acid substitution pattern in core protein of hepatitis C virus genotype 1b high viral load and non-virological response to interferon-ribavirin combination therapy. Intervirology 2005; 48:372-80.
27. Torres-Puente M, Cuevas JM, Jimenez-Hernandez N, et al. Hepatitis C virus and the controversial role of the interferon sensitivity determining region in the response to interferon treatment. J Med Virol 2008; 80:247-53.
28. Buckton AJ, Ngui SL, Arnold C, et al. Multitypic hepatitis C virus infection identified by real-time nucleotide sequencing of minority genotypes. J Clin Microbiol 2006; 44:2779-84.
29. Stikleryte A, Griskeviciene J, Magnius LO, Zagminas K, Norder H, Ambrozaitis A. Characterization of HCV strains in an oncohematological pediatric department reveals little horizontal transmission but multiple introductions by un-screened blood products in the past. J Med Virol 2006; 78:1411-22.
30. Shustov AV, Kochneva GV, Sivolobova GF, et al. Molecular epidemiology of the hepatitis C virus in Western Siberia. J Med Virol 2005; 77:382-9.
31. Kurbanov F, Tanaka Y, Sugauchi F, et al. Hepatitis C virus molecular epidemiology in Uzbekistan. J Med Virol 2003; 69:367-75.
32. Blackard JT, Sherman KE. Hepatitis C virus coinfection and superinfection. J Infect Dis 2007; 195:519-24.
33. Tscherne DM, Evans MJ, von Hahn T, et al. Superinfection exclusion in cells infected with hepatitis C virus. J Virol 2007; 81:3693-703.
34. Schaller T, Appel N, Koutsoudakis G, et al. Analysis of hepatitis C virus superinfection exclusion by using novel fluorochrome gene-tagged viral genomes. J Virol 2007; 81:4591-603.
35. Pybus OG, Rambaut A, Harvey PH. An integrated framework for the inference of viral population history from reconstructed genealogies. Genetics 2000; 155:1429-37.
36. Pybus OG, Charleston MA, Gupta S, Rambaut A, Holmes EC, Harvey PH. The epidemic behavior of the hepatitis C virus. Science 2001; 292:2323-5.
37. Tanaka Y, Kurbanov F, Mano S, et al. Molecular tracing of the global hepatitis C virus epidemic predicts regional patterns of hepatocellular carcinoma mortality. Gastroenterology 2006; 130:703-14.
38. Nakano T, Lu L, Liu P, Pybus OG. Viral gene sequences reveal the variable history of hepatitis C virus infection among countries. J Infect Dis 2004; 190:1098-108.